Former U.S. Congressman Erik Paulsen Joins Cardiovascular Systems Board of Directors

OrthoNext Digital Platform for the JuniOrtho Plating System Receives FDA Clearance

“Together, OrthoNext and the JuniOrtho Plating System provide a complete solution for surgeons looking for a plating system to address the specific demands of advanced deformity and trauma reconstruction of the lower extremities in the pediatric population,” said Orthofix President of Global Orthopedics Paul Gonsalves.

SonarMed, New Pediatric Monitor Alerts Clinicians To Potential Airway Obstructions During Ventilation Launched

"The SonarMed airway monitoring device has revolutionized the way we care for our littlest patients. There is no other device in the world that can tell you where the endotracheal tube is located within the airway continuously in real-time, and whether the tube is obstructed or even partially occluded," said Jamie W. Powers, M.D., MBA, neonatologist at Huntington Hospital in Pasadena, California.

Cardiovascular Systems, Inc. announced the addition of independent board member Erik Paulsen. He replaces director Scott Bartos, who is retiring from the board after seven years of service. The CSI board continues to have seven directors, six of whom are independent.

From 2009 to 2019, Paulsen represented Minnesota’s Third Congressional District in the United States House of Representatives. During his tenure, Paulsen was a leading member on the House Ways and Means Committee, the House’s tax-writing body with broad jurisdiction over healthcare, economic and trade policy. He also served as Chairman of Congress’ Joint Economic Committee, a unique House-Senate panel tasked with working alongside the President’s Council of Economic Advisors and the Federal Reserve Board to identify and address macroeconomic trends. Paulsen was co-chair of the bipartisan House Medical Technology Caucus, as well. Prior to his service in Congress, Paulsen was a member of the Minnesota State Legislature, where he served as House Majority Leader. Paulsen has over 16 years of business experience, including working as a business analyst at Target Corporation.

“During his time as a member of the United States House of Representatives, Erik was a strong advocate for the medical technology industry, the life-saving technologies it provides to patients and the hundreds of thousands of jobs it supports,” said Scott Ward, CSI Chairman, President and Chief Executive Officer. “His leadership and experience in government affairs will be invaluable as CSI seeks to expand the number of patients it serves.”

Said Ward, “We thank Scott Bartos for his many contributions to CSI throughout the past seven years. During his tenure, over 400,000 patients benefitted from orbital atherectomy. Scott’s counsel helped shape CSI’s strategy as we transform this company from a single technology, single geography company to an innovative leader with worldwide reach.”

 

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles